immuno-oncology

News

ACCC Releases Report on Current State of Immuno-Oncology

07/01/2020

The Association of Community Cancer Centers (ACCC) Immuno-Oncology Institute released an assessment of the current state of immuno-oncology that highlights for cancer care professionals the current research,...

The...

07/01/2020

Journal of Clinical Pathways

News

Real-World Costs of Adverse Events After First-Line Treatment of Metastatic NSCLC

06/09/2020

Real-world patients with metastatic non-small cell lung cancer (NSCLC) who receive first-line immunotherapy are less likely to incur adverse event-related costs than those treated with first-line cytotoxic...

...

06/09/2020

Journal of Clinical Pathways

Department

Trial Shows Precision Medicine Improves Cancer Survival

09/28/2016

JCP Editors

Data from the Paris-based Molecular Screening for Cancer Treatment Optimization (MOSCATO) trial demonstrates that establishing molecular portraits improves survival for patients with advanced cancer by tailoring...

Data...

09/28/2016

Journal of Clinical Pathways

Novel Therapies for Blood Diseases

02/15/2016

JCP Editors

New research on the genetics of different cancers has propelled the advance of new, novel treatment methods for diseases such as leukemia, lymphoma, and myeloma. The 57th ASH Annual Meeting and Exposition was a major...

New...

02/15/2016

Journal of Clinical Pathways

Overall Survival for Progressive Bladder Cancer Improved with Personalized Peptide Vaccination

12/01/2015

JCP Editors

A new immunotherapy may help to improve outcomes of patients with metastatic bladder cancer, according to the results of a Phase II study. Bladder cancer is one of the most common and deadly forms of cancer for men...

A new...

12/01/2015

Journal of Clinical Pathways